FrancophonIA/ELRC3.0 huggingface dataset:
English: To benefit from your medicine you should take it regularly every day at the same time of the day.
Slovenian: Zdravilo Memantin Mylan jemljite peroralno enkrat na dan. Da bi vam zdravilo koristilo, ga morate jemati redno, vsak dan ob istem času.
English: What Memantine Mylan contains - The active substance is memantine.
Slovenian: Kaj vsebuje zdravilo Memantin Mylan - Učinkovina je memantin.
English: In man, about 80% of the circulating memantine-related material is present as the parent compound.
Slovenian: Pri človeku je okoli 80 % memantina v obtoku v izvorni (nespremenjeni) obliki.
English: The pack sizes 28 x 1, 56 x 1, 98 x 1 and 100 x 1 film-coated tablets are presented in clear PVC-PVdC film with push through aluminium foil lidding perforated unit dose blisters.
Slovenian: Velikosti pakiranj s po 28 x 1, 56 x 1, 98 x 1 in 100 x 1 filmsko obloženo tableto so na voljo v prozornih PVC-PVdC/Alu perforiranih enoodmernih pretisnih omotih.
English: Fungal infections
Slovenian: Žilne bolezni
English: Memantine Mylan contains the active substance memantine.
Slovenian: Zdravilo Memantin Mylan vsebuje učinkovino memantin.
English: Week 3 (day 15-21): The patient should take one and a half 10 mg film-coated tablets (15 mg) per day for 7 days.
Slovenian: 3. teden (15.-21. dan): Bolnik mora sedem dni jemati eno in pol 10-miligramsko filmsko obloženo tableto (15 mg) na dan.
English: Administration of Memantine Mylan is not recommended in patients with severe hepatic impairment.
Slovenian: Dajanje zdravila Memantin Mylan bolnikom s hudo jetrno okvaro ni priporočljivo.
English: • There may be a possibility of reduced serum level of hydrochlorothiazide (HCT) when memantine is coadministered with HCT or any combination with HCT.
Slovenian: • Ob sočasni uporabi memantina in hidroklorotiazida (HCT) oziroma zdravil, ki vsebujejo HCT, lahko pride do zmanjšanja serumske koncentracije HCT.
English: Week 2 (day 8-14): The patient should take one 10 mg film-coated tablet (10 mg) per day for 7 days.
Slovenian: 2. teden (8.-14. dan): Bolnik mora sedem dni jemati eno 10-miligramsko filmsko obloženo tableto (10 mg) na dan.
English: These events have been reported in patients treated with memantine hydrochloride.
Slovenian: Pri bolnikih, zdravljenih z memantinom, so poročali o teh dogodkih.
English: Titanium dioxide (E171)
Slovenian: Dodatno za 10 mg filmsko obložene tablete: titanov dioksid (E171) rumeni železov oksid (E 172) indigotin (E132)
English: • Concomitant use of memantine and amantadine should be avoided, owing to the risk of pharmacotoxic psychosis.
Slovenian: • Zaradi možnosti pojava farmakotoksične psihoze, se je sočasni uporabi memantina in amantadina potrebno izogniti.
English: Dose titration
Slovenian: PRETISNI OMOT
English: Week 1 (day 1-7): The patient should take half a 10 mg film-coated tablet (5 mg) per day for 7 days.
Slovenian: 1. teden (1.-7. dan): Bolnik mora sedem dni jemati polovico 10-miligramske filmsko obložene tablete (5 mg) na dan.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS BLISTER
Slovenian: PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA PRETISNEM OMOTU ALI TRAKU
English: What Memantine Mylan looks like and contents of the pack A red film-coated, oval, biconvex, beveled edge tablet marked with “ME” on one side of the tablet and “20” on the other side.
Slovenian: Izgled zdravila Memantin Mylan in vsebina pakiranja Rdeče, ovalne, bikonveksne filmsko obložene tablete s prirezanim robom in označene z "ME" na eni strani tablete in "20" na drugi strani.
English: A red film-coated, oval, biconvex, bevelled edge tablet debossed with “ME” on one side of the tablet and “20” on the other side.
Slovenian: Rdeče, ovalne, bikonveksne filmsko obložene tablete s prirezanim robom in z vtisnjeno oznako "ME" na eni strani tablete in "20" na drugi strani.
English: Tel: + 39 02 612 46921
Slovenian: Mylan S.p.A Tel: + 39 02 612 46921
English: A dark yellow film-coated, tapered oblong shaped, biconvex tablet debossed with “ME” on the left of the score and “10” on the right of the score on one side of the tablet and a score on the other side.
Slovenian: Temno rumene, stožčaste, podolgovate, bikonveksne filmsko obložene tablete, z vtisnjeno oznako "ME" levo in "10" desno od razdelilne zareze na eni strani tablete ter razdelilno zarezo na drugi strani.
English: The following adverse reactions listed in the Table below have been accumulated in clinical studies with memantine and since its introduction in the market.
Slovenian: V spodnji preglednici so navedeni podatki o neželenih učinkih memantina, zbrani v kliničnih študijah in v obdobju trženja zdravila.
English: How to store Memantine Mylan
Slovenian: Shranjevanje zdravila Memantin Mylan
English: In post-marketing experience these reactions have been reported in patients treated with memantine.
Slovenian: Pri bolnikih, zdravljenih z memantinom, so o teh učinkih poročali v okviru izkušenj v obdobju trženja zdravila.
English: Hepatic impairment
Slovenian: Neznana hepatitis
English: What Memantine Mylan looks like and contents of the pack A dark yellow film-coated, tapered oblong shaped, biconvex tablet marked with “ME” on the left of the score and “10” on the right of the score on one side of the tablet and a score on the other side.
Slovenian: Izgled zdravila Memantin Mylan in vsebina pakiranja Temno rumene, stožčaste, podolgovate, bikonveksne filmsko obložene tablete, označene z "ME" levo in "10" desno od razdelilne zareze na eni strani tablete ter razdelilno zarezo na drugi strani.
English: In the most extreme case of overdose, the patient survived the oral intake of a total of 2000 mg memantine with effects on the central nervous system (coma for 10 days, and later diplopia and agitation).
Slovenian: Pojavili so se učinki na centralni živčni sistem (desetdnevna koma, kasneje diplopija in vznemirjenost).
English: one and a half 10 mg tablets week 4 and beyond two 10 mg tablets once a day
Slovenian: 4. teden in naprej dve 10-miligramski tableti enkrat na dan
English: In another monotherapy study in mild to moderate Alzheimer's disease a total of 470 patients (MMSE total scores at baseline of 11-23) were randomised.
Slovenian: V drugi študiji zdravljenja z monoterapijo pri blagi do zmerni Alzheimerjevi bolezni (skupna ocena KPSS ob vključitvi 11 do 23 točk), je bilo zajetih in naključno razdeljenih 470 bolnikov.
English: This is increased to one 10 mg tablet once a day (10 mg) in the second week and to 1 and a half 10 mg tablets once a day in the third week.
Slovenian: V drugem tednu odmerek povišamo na eno 10-miligramsko tableto enkrat na dan (10 mg) in v tretjem tednu na eno 10-miligramsko tableto in pol enkrat na dan. Od četrtega tedna naprej sta običajni odmerek dve 10-miligramski tableti enkrat na dan (20 mg).
English: Memantine Mylan 20 mg film-coated tablets
Slovenian: Memantin Mylan 20 mg filmsko obložene tablete
English: Memantine Mylan 10 mg film-coated tablets
Slovenian: Memantin Mylan 10 mg filmsko obložene tablete
English: Gait abnormal
Slovenian: Občasni nenormalna hoja
English: If you get any side effects, talk to your doctor or pharmacist.
Slovenian: Če opazite kateri koli neželeni učinek, se posvetujte s svojim zdravnikom, farmacevtom ali z medicinsko sestro.
English: NAME OF THE MEDICINAL PRODUCT Memantine Mylan 10 mg film-coated tablets Memantine Mylan 20 mg film-coated tablets
Slovenian: Memantin Mylan 10 mg filmsko obložene tablete Memantin Mylan 20 mg filmsko obložene tablete
English: EU/1/13/827/033 98 x 1 film-coated tablets EU/1/13/827/034 100 film-coated tablets EU/1/13/827/035 100 x 1 film-coated tablets EU/1/13/827/036 112 film-coated tablets
Slovenian: EU/1/13/827/033 98 x 1 filmsko obložena tableta EU/1/13/827/034 100 filmsko obloženih tablet EU/1/13/827/035 100 x 1 filmsko obložena tableta EU/1/13/827/036 112 filmsko obloženih tablet
English: EU/1/13/827/015 98 x 1 film-coated tablets EU/1/13/827/016 100 film-coated tablets EU/1/13/827/017 100 x 1 film-coated tablets EU/1/13/827/018 112 film-coated tablets
Slovenian: EU/1/13/827/015 98 x 1 filmsko obložena tableta EU/1/13/827/016 100 filmsko obloženih tablet EU/1/13/827/017 100 x 1 filmsko obložena tableta EU/1/13/827/018 112 filmsko obloženih tablet
English: A pivotal monotherapy study in a population of patients suffering from moderate to severe Alzheimer's disease (mini mental state examination (MMSE) total scores at baseline of 3 - 14) included a total of 252 outpatients.
Slovenian: V temeljno klinično študijo je bilo vključenih 252 bolnikov z zmerno do hudo Alzheimerjevo boleznijo, ki so ob vključitvi pri kratkem preizkusu spoznavnih sposobnosti (MMSE - mini-mental state examination) dosegli 3-14 točk.
English: There was no evidence of any carcinogenicity in life long studies in mice and rats.
Slovenian: V šudijah na miših in podganah, ki so potekale celo življenjsko dobo, niso opazili karcinogenosti.
English: one and a half 10 mg tablets week 4 and beyond one 20 mg tablet once a day
Slovenian: 4. teden in naprej ena 20-miligramska tableta enkrat na dan
English: EU/1/13/827/007 42 film-coated tablets
Slovenian: EU/1/13/827/007 42 filmsko obloženih tablet
English: EU/1/13/827/025 42 film-coated tablets
Slovenian: EU/1/13/827/025 42 filmsko obloženih tablet
English: Memantine Mylan 10 mg film-coated tablets memantine hydrochloride
Slovenian: Memantin Mylan 10 mg filmsko obložene tablete memantinijev klorid
English: Memantine Mylan 20 mg film-coated tablets memantine hydrochloride
Slovenian: Memantin Mylan 20 mg filmsko obložene tablete memantinijev klorid
English: EU/1/13/827/005 28 x 1 film-coated tablets EU/1/13/827/006 30 film-coated tablets
Slovenian: EU/1/13/827/005 28 x 1 filmsko obložena tableta EU/1/13/827/006 30 filmsko obloženih tablet
English: EU/1/13/827/022 28 film-coated tablets
Slovenian: EU/1/13/827/022 28 filmsko obloženih tablet
English: EU/1/13/827/019 7 film-coated tablets
Slovenian: EU/1/13/827/019 7 filmsko obloženih tablet
English: EU/1/13/827/030 70 film-coated tablets
Slovenian: EU/1/13/827/030 70 filmsko obloženih tablet
English: EU/1/13/827/023 28 x 1 film-coated tablets EU/1/13/827/024 30 film-coated tablets
Slovenian: EU/1/13/827/023 28 x 1 filmsko obložena tableta EU/1/13/827/024 30 filmsko obloženih tablet
English: EU/1/13/827/032 98 film-coated tablets
Slovenian: EU/1/13/827/032 98 filmsko obloženih tablet
English: EU/1/13/827/020 10 film-coated tablets
Slovenian: EU/1/13/827/020 10 filmsko obloženih tablet
English: EU/1/13/827/010 56 x 1 film-coated tablets EU/1/13/827/011 60 film-coated tablets
Slovenian: EU/1/13/827/010 56 x 1 filmsko obložena tableta EU/1/13/827/011 60 filmsko obloženih tablet
English: Silica, colloidal anhydrous
Slovenian: Bolezni jeter, žolčnika in žolčevodov
English: EU/1/13/827/009 56 film-coated tablets
Slovenian: EU/1/13/827/009 56 filmsko obloženih tablet
English: Continue to take Memantine Mylan as long as it is of benefit to you.
Slovenian: Zdravilo Memantin Mylan jemljite tako dolgo, kot vam pomaga in se ne pojavijo neželeni učinki, ki jih ne prenašate.
English: EU/1/13/827/027 56 film-coated tablets
Slovenian: EU/1/13/827/027 56 filmsko obloženih tablet
English: EU/1/13/827/008 50 film-coated tablets
Slovenian: EU/1/13/827/008 50 filmsko obloženih tablet
English: EU/1/13/827/026 50 film-coated tablets
Slovenian: EU/1/13/827/026 50 filmsko obloženih tablet
English: EU/1/13/827/004 28 film-coated tablets
Slovenian: EU/1/13/827/004 28 filmsko obloženih tablet
English: EU/1/13/827/002 10 film-coated tablets
Slovenian: EU/1/13/827/002 10 filmsko obloženih tablet
English: one 10 mg tablet week 3
Slovenian: 2. teden ena 10-miligramska tableta
English: EU/1/13/827/028 56 x 1 film-coated tablets EU/1/13/827/029 60 film-coated tablets
Slovenian: EU/1/13/827/028 56 x 1 filmsko obložena tableta EU/1/13/827/029 60 filmsko obloženih tablet
English: EU/1/13/827/021 14 film-coated tablets
Slovenian: EU/1/13/827/021 14 filmsko obloženih tablet
English: EU/1/13/827/014 98 film-coated tablets
Slovenian: EU/1/13/827/014 98 filmsko obloženih tablet
English: EU/1/13/827/031 84 film-coated tablets
Slovenian: EU/1/13/827/031 84 filmsko obloženih tablet
English: Drug hypersensitivity
Slovenian: Pogosti hipertenzija
English: EU/1/13/827/012 70 film-coated tablets
Slovenian: EU/1/13/827/012 70 filmsko obloženih tablet
English: EU/1/13/827/001 7 film-coated tablets
Slovenian: EU/1/13/827/001 7 filmsko obloženih tablet
English: Very rare
Slovenian: Pogosti dispneja
English: EU/1/13/827/013 84 film-coated tablets
Slovenian: EU/1/13/827/013 84 filmsko obloženih tablet
English: EU/1/13/827/003 14 film-coated tablets
Slovenian: EU/1/13/827/003 14 filmsko obloženih tablet
English: No cytochrome P 450 catalysed metabolism has been detected in vitro.
Slovenian: Noben od teh presnovkov nima antagonističnega učinka na NMDA. In vitro niso zaznali presnove preko citokroma P 450.
English: Balance disorders
Slovenian: Pogosti motnje ravnotežja
English: half a 10 mg tablet week 2
Slovenian: 3. teden ena in pol 10-miligramska tableta
English: Hypertension
Slovenian: Linearnost
English: • Inflammation of the pancreas, inflammation of the liver (hepatitis) and psychotic reactions Alzheimer's disease has been associated with depression, suicidal ideation and suicide.
Slovenian: Obstaja povezava med Alzheimerjevo boleznijo in depresijo, samomorilnimi mislimi in samomorom.
English: It is a well-known substance, which has been used to control pain for many years.
Slovenian: To je dobro znana snov, ki se že več let uporablja za obvladovanje bolečin.
English: Further information on PecFent can be found on the Agency's website: EMA website/Find medicine/Human medicines/European Public Assessment Reports.
Slovenian: Nadaljnje informacije za zdravilo PecFent so na voljo na spletni strani agencije: EMA website/Find medicine/Human medicines/European Public Assessment Reports.
English: This means that it is similar to ‘reference medicines' containing the same active substance, but given in a different way.
Slovenian: To pomeni, da je podobno „referenčnima zdraviloma“, ki vsebujeta enako učinkovino, vendar se dajeta na drugačen način.
English: What measures are being taken to ensure the safe and effective use of PecFent?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila PecFent?
English: PecFent (fentanyl)
Slovenian: PecFent (fentanil)
English: PecFent received a marketing authorisation valid throughout the EU on 31 August 2010.
Slovenian: Za zdravilo PecFent je bilo 31. avgusta 2010 izdano dovoljenje za promet, veljavno po vsej EU.
English: The first trial dose should always be 100 micrograms (one spray into one nostril).
Slovenian: Prvi poskusni odmerek mora biti vedno 100 mikrogramov (en vpih pršila v eno nosnico).
English: Based on available data, the Agency concluded that PecFent's benefits are greater than its risks and it can be authorised for use in the EU.
Slovenian: Na podlagi razpoložljivih podatkov je agencija zaključila, da so koristi zdravila PecFent večje od z njim povezanih tveganj in da se lahko odobri za uporabo v EU.
English: The average reduction in pain during the first 30 minutes after use was 6.6 points in patients receiving PecFent compared with 4.5 in those receiving placebo.
Slovenian: V prvih 30 minutah po uporabi se je bolečina pri bolnikih, ki so prejemali zdravilo PecFent, povprečno zmanjšala za 6,6 točke, pri bolnikih, ki so prejemali placebo, pa za 4,5 točke.
English: Other information about PecFent:
Slovenian: Druge informacije o zdravilu PecFent:
English: The main measure of effectiveness was the change in the severity of pain measured by the patients ranking their pain on a scale from 0 to 10.
Slovenian: Glavno merilo učinkovitosti je bila sprememba jakosti bolečine, ki so jo bolniki ocenili na lestvici od 0 do 10.
English: Because PecFent is a hybrid medicine, the applicant presented data on the reference medicines in addition to results from its own studies.
Slovenian: Ker je zdravilo PecFent hibridno zdravilo, je predlagatelj poleg rezultatov svojih študij predložil tudi podatke o referenčnih zdravilih.
English: Patients should not take more than four doses a day and should leave a gap of at least four hours between treating each episode of pain.
Slovenian: Bolniki ne smejo prejeti več kot štiri odmerke dnevno, poleg tega mora biti med zdravljenjem posamičnih epizod bolečine najmanj štiriurni premor.
English: An overview of PecFent and why it is authorised in the EU
Slovenian: Pregled zdravila PecFent in zakaj je odobreno v EU
English: The most serious of these side effects are respiratory depression (inhibition of breathing), circulatory depression (slow heartbeat), hypotension (low blood pressure) and shock (a steep fall in blood pressure).
Slovenian: Najresnejši od teh neželenih učinkov so depresija dihanja (oteženo dihanje), depresija krvnega obtoka (počasen srčni utrip), hipotenzija (nizek krvni tlak) in šok (močan padec krvnega tlaka).
English: As for all medicines, data on the use of PecFent are continuously monitored.
Slovenian: Tako kot za vsako zdravilo se tudi podatki o uporabi zdravila PecFent stalno spremljajo.
English: What are the risks associated with PecFent?
Slovenian: Kakšna tveganja so povezana z zdravilom PecFent?
English: PecFent is a ‘hybrid medicine'.
Slovenian: Zdravilo PecFent je „hibridno zdravilo“.
English: In this study, patients reported that they were ‘satisfied' or ‘very satisfied' with PecFent treatment for around 90% of breakthrough pain episodes.
Slovenian: V tej študiji so bolniki poročali, da so z zdravljenjem z zdravilom PecFent „zadovoljni“ ali „zelo zadovoljni“ pri približno 90 % epizod prebijajoče bolečine.
English: What benefits of PecFent have been shown in studies?
Slovenian: Kakšne koristi zdravila PecFent so se pokazale v študijah?
English: When a patient starts to take PecFent the doctor will need to work out the appropriate dose that will provide adequate pain relief with as few side effects as possible.
Slovenian: Ko začne bolnik prejemati zdravilo PecFent, mora zdravnik določiti ustrezen odmerek, ki bo zagotovil primerno lajšanje bolečin s čim manj neželenimi učinki.
English: Why is PecFent authorised in the EU?
Slovenian: Zakaj je bilo zdravilo PecFent odobreno v EU?
English: The doctor should keep in mind the potential for PecFent to be abused.
Slovenian: Zdravnik se mora zavedati, da obstaja možnost zlorabe zdravila PecFent.
English: Side effects reported with PecFent are carefully evaluated and any necessary action taken to protect patients.
Slovenian: Neželeni učinki, o katerih so poročali pri zdravilu PecFent, se skrbno ovrednotijo in po potrebi se sprejmejo ukrepi za zaščito bolnikov.
English: The European Medicines Agency noted that there was a need for fast-acting pain medicines for breakthrough pain in patients with cancer.
Slovenian: Evropska agencija za zdravila ugotovila, da obstaja potreba po hitro delujočih protibolečinskih zdravilih za zdravljenje prebijajoče bolečine pri bolnikih z rakom.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of PecFent have also been included in the summary of product characteristics and the package leaflet.
Slovenian: Priporočila in previdnostni ukrepi, ki jih morajo za varno in učinkovito uporabo zdravila PecFent upoštevati zdravstveni delavci in bolniki, so vključeni tudi v povzetek glavnih značilnosti zdravila in navodilo za uporabo.
English: The company that markets PecFent will provide educational materials in each EU Member State to make sure that patients, doctors and pharmacists are aware of how PecFent should be used, the risk of accidental exposure to fentanyl and how to dispose of the medicine.
Slovenian: Podjetje, ki trži zdravilo PecFent, bo v vseh državah članicah EU priskrbelo izobraževalno gradivo in z njim zagotovilo, da so bolniki, zdravniki in farmacevti seznanjeni s pravilno uporabo zdravila PecFent, tveganjem v primeru nenamerne izpostavitve fentanilu in načinom odstranjevanja zdravila.
English: PecFent is available as a nasal spray (100 and 400 micrograms per spray) and can only be obtained by ‘special' prescription.
Slovenian: Zdravilo PecFent je na voljo kot pršilo za nos (100 in 400 mikrogramov na vpih pršila), njegovo predpisovanje in izdaja pa je le na „poseben“ recept.
English: For more information about using PecFent, see the package leaflet or contact your doctor or pharmacist.
Slovenian: Za več informacij glede uporabe zdravila PecFent glejte navodilo za uporabo ali se posvetujte z zdravnikom ali farmacevtom.
English: What is PecFent and what is it used for?
Slovenian: Kaj je zdravilo PecFent in za kaj se uporablja?
English: PecFent must not be used in patients who are not already taking opioids to maintain pain control, who have severe respiratory depression (inhibition of breathing) or who have severe obstructive lung conditions (diseases that severely impede breathing).
Slovenian: Zdravila PecFent ne smejo uporabljati bolniki, ki še ne jemljejo opioidov za vzdrževanje nadzora nad bolečino, in bolniki, ki imajo resno depresijo dihanja (oteženo dihanje) ali obolenje s hudo obstrukcijo pljuč (bolezen, pri kateri je dihanje močno ovirano).
English: In one main study, PecFent was shown to be more effective than placebo (a dummy treatment) at treating breakthrough cancer pain in 83 adults who were being treated with opioids.
Slovenian: V eni glavni študiji se je pokazalo, da je zdravilo PecFent za zdravljenje prebijajoče bolečine učinkovitejše kot placebo (zdravilo brez učinkovine) pri 83 odraslih z rakom, ki so se zdravili z opioidi.
English: When the patient sprays PecFent into the nose, a dose of fentanyl is rapidly absorbed into the blood stream through the blood vessels in the nose.
Slovenian: Ko si bolnik naprši zdravilo PecFent v nos, se odmerek fentanila skozi krvne žile v nosu hitro absorbira v krvni obtok.
English: The doses should be given as either one spray or two sprays of the same strength.
Slovenian: Zdravilo je treba odmerjati bodisi z enim ali dvema vpihoma pršila enake jakosti.
English: An additional study measured the ‘acceptability' of PecFent by the patients, rating how satisfied they were with PecFent, and how easy and convenient they found it to use.
Slovenian: V dodatni študiji so merili „sprejemljivost“ zdravila PecFent, in sicer so bolniki ocenjevali zadovoljstvo z zdravilom PecFent ter enostavnost in priročnost njegove uporabe.
English: While the reference medicines Effentora (buccal tablets) and Actiq (lozenges) are taken by mouth, PecFent is given as a spray into the nose.
Slovenian: Medtem ko se referenčni zdravili Effentora (bukalne tablete) in Actiq (pastile) dajeta peroralno, se zdravilo PecFent daje kot pršilo v nos.
English: Breakthrough pain is when a patient experiences additional, sudden pain in spite of ongoing treatment with painkillers.
Slovenian: O prebijajoči bolečini govorimo takrat, ko bolnik občuti nenadno dodatno bolečino, čeprav že prejema protibolečinska zdravila.
English: It must not be used to treat short-term pain other than breakthrough pain.
Slovenian: Zdravilo se ne sme uporabljati za zdravljenje drugih vrst kratkotrajnih bolečin.
English: PecFent is used in patients who are already using opioids (a group of painkillers that includes morphine and fentanyl) to control long-term cancer pain.
Slovenian: Zdravilo PecFent se uporablja pri bolnikih, ki že jemljejo opioide (zdravila iz skupine protibolečinskih zdravil, kamor spadata morfin in fentanil) za obvladovanje dolgotrajne bolečine pri raku.
English: PecFent is a medicine used to treat breakthrough pain in adult patients with cancer.
Slovenian: PecFent je zdravilo za zdravljenje prebijajoče bolečine pri odraslih bolnikih z rakom.
English: The active substance in PecFent, fentanyl, is an opioid.
Slovenian: Učinkovina v zdravilu PecFent, fentanil, je opioid.
English: Treatment with PecFent should be started by and remain under the supervision of a doctor who has experience in managing opioid treatment in cancer patients.
Slovenian: Zdravljenje z zdravilom PecFent sme uvesti in ves čas voditi le zdravnik, ki ima izkušnje z izvajanjem zdravljenja z opioidi pri bolnikih z rakom.
English: How is PecFent used?
Slovenian: Kako se zdravilo PecFent uporablja?
English: PecFent contains the active substance fentanyl.
Slovenian: Zdravilo PecFent vsebuje učinkovino fentanil.